On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1999-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM.84.5.5652PMID 10323380
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trabecular bone structure in patients with primary hyperparathyroidism

  2004cited by this paper
• Effects of Ethnicity and Age or Menopause on Osteoblast Function, Bone Mineralization, and Osteoid Accumulation in Iliac Bone

  1997cited by this paper
• Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.

  1997cited by this paper
• Exploiting and Bypassing the Bone Remodeling Cycle to Optimize the Treatment of Osteoporosis

  1997cited by this paper
• Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women

  1995cited by this paper
• Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism.

  1995cited by this paper
• Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism.

  1995cited by this paper
• Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH(1-84)) in patients with primary hyperparathyroidism.

  1993cited by this paper
• Anabolic actions of parathyroid hormone on bone.

  1993cited by this paper
• Primary hyperparathyroidism: iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods.

  1992influential reference
• Maintenance of cancellous bone connectivity in primary hyperparathyroidism: Trabecular strut analysis

  1992cited by this paper
• Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: evidence for de novo bone formation on quiescent cancellous surfaces.

  1992cited by this paper
• Treatment of osteoporosis with parathyroid peptide (hPTH 1–34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone

  1992cited by this paper
• The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure.

  1990cited by this paper
• Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures.

  1989cited by this paper
• Skeletal disease in primary hyperparathyroidism

  1989cited by this paper
• Static and tetracycline‐based bone histomorphometric data from 34 normal postmenopausal females

  1988cited by this paper
• Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

  1987cited by this paper
• Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

  1987cited by this paper
• Bone morphology in primary hyperparathyroidism--a qualitative and quantitative study of 391 cases.

  1987cited by this paper
• Parathyroid hormone stimulates the proliferation of cells derived from human bone.

  1986cited by this paper
• Trabecular bone remodeling and balance in primary hyperparathyroidism.

  1986cited by this paper
• Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.

  1983cited by this paper
• Effects of parathyroid hormone on remodeling of iliac trabecular bone packets in patients with primary hyperparathyroidism.

  1982cited by this paper
• Estimation of the three-dimensional wall thickness of completed remodeling sites in iliac trabecular bone.

  1982cited by this paper
• The label escape error: determination of the active bone-forming surface in histologic sections of bone measured by tetracycline double labels.

  1982cited by this paper

• Parathyroid hormone receptor agonists in the management of osteoporosis

  2025cites this paper
• Morphometric Analysis of Bone Lesions in a Patient With End-stage Renal Failure Due to Primary Hyperparathyroidism

  2025cites this paper
• Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes

  2025cites this paper
• Chapter 3: IMPACT OF PRIMARY HYPERPARATHYROIDISM.

  2025cites this paper
• Bone Disease in Primary Hyperparathyroidism

  2025cites this paper
• Using Texture Analysis of Neck Computed Tomography Images to Differentiate Primary Hyperparathyroidism From Normal Controls

  2023cites this paper
• Degraded Bone Microarchitecture in Women with PHPT–Significant Predictor of Fracture Probability

  2023cites this paper
• Site specific differences in vBMD and geometry in postmenopausal women with primary hyperparathyroidism

  2023cites this paper
• Increased PHOSPHO1 and alkaline phosphatase expression during the anabolic bone response to intermittent parathyroid hormone delivery

  2022cites this paper
• Circulating miR-122-5p and miR-375 as Potential Biomarkers for Bone Mass Recovery after Parathyroidectomy in Patients with Primary Hyperparathyroidism: A Proof-of-Concept Study

  2021cites this paper
• Primary Hyperparathyroidism: Pathophysiology, Surgical Indications, and Preoperative Workup

  2021cites this paper
• Bone microarchitecture and estimated failure load are deteriorated whether patients with chronic kidney disease have normal bone mineral density, osteopenia or osteoporosis.

  2021cites this paper
• Bone Analysis by the Trabecular Bone Score and 3D-DXA in Postmenopausal Women with Primary Hyperparathyroidism.

  2021cites this paper
• The skeletal actions of parathyroid hormone in primary hyperparathyroidism

  2021cites this paper
• Skeletal abnormalities in Hypoparathyroidism and in Primary Hyperparathyroidism

  2020cites this paper
• Parathyroid hormone and parathyroid hormone–related protein actions on bone and kidney

  2020cites this paper
• PTH and PTHrP Analogs: Treatment of Osteoporosis

  2020cites this paper
• Pharmacologic mechanisms of therapeutics

  2020cites this paper
• Effects of PTH and PTH Hypersecretion on Bone: a Clinical Perspective

  2020cites this paper
• Calcium homeostasis during hibernation and in mechanical environments disrupting calcium homeostasis

  2020cites this paper
• Cellular actions of parathyroid hormone on bone

  2020cites this paper
• Effect of Endogenous Parathyroid Hormone on Bone Geometry and Skeletal Microarchitecture

  2019cites this paper
• Association between intermittent administration of parathyroid

  2019cites this paper
• [Prolonged continuous infusion of teriparatide promotes bone metabolism in normal but not in castrated mice].

  2019cites this paper
• Thiol‐ene Hydrogels for Local Delivery of PTH for Bone Regeneration in Critical Size defects

  2019cites this paper
• The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone

  2018cites this paper
• Skeletal Manifestations of Hyperparathyroidism

  2018cites this paper
• Association between intermittent administration of parathyroid hormone 1-34 and ectopic calcification in rats

  2018cites this paper
• Skeletal Manifestations of Hyperparathyroidism Ahmed

  2018cites this paper
• The Effects of Long‐term Administration of rhPTH(1‐84) in Hypoparathyroidism by Bone Histomorphometry

  2018influential citation
• Parathyroid hormone for bone regeneration

  2018cites this paper
• Classical complications of primary hyperparathyroidism.

  2018cites this paper
• Primary Hyperparathyroidism; Current Management Guidelines

  2017cites this paper
• Regulation of skeletal mineralisation by PHOSPHO1.

  2017cites this paper
• Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism – translating the pharmacology

  2017cites this paper
• ANNALS OF THE NEW YORK ACADEMY OF SCIENCES MARROW

  2016cites this paper
• T cells, osteoblasts, and osteocytes: interacting lineages key for the bone anabolic and catabolic activities of parathyroid hormone

  2016cites this paper
• The Expression of PHOSPHO1, nSMase2 and TNAP is Coordinately Regulated by Continuous PTH Exposure in Mineralising Osteoblast Cultures

  2016cites this paper
• The Role of IL-17 and TH17 Cells in the Bone Catabolic Activity of PTH

  2016cites this paper
• Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism

  2015cites this paper
• Bone Histomorphometry and Bone Quality in Primary Hyperparathyroidism

  2015cites this paper
• 193 – Rheumatoid manifestations of endocrine and lipid disease

  2015cites this paper
• Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology.

  2015cites this paper
• Cortical Bone: A Challenging Geography

  2015cites this paper
• PTH and T-cell Biology

  2015cites this paper
• Endocrine regulation of bone and energy metabolism in hibernating mammals.

  2014cites this paper
• Factors associated with vertebral fracture risk in patients with primary hyperparathyroidism.

  2014cites this paper
• Capítulo 10 – Hiperparatiroidismo primario y hueso

  2014cites this paper
• Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

  2014cites this paper
• Effects of laparoscopic Roux-en-Y gastric bypass on bone mineral density and markers of bone turnover.

  2014cites this paper
• A Computational Model for Simulating Spaceflight Induced Bone Remodeling

  2014cites this paper
• Vitamin D in health of seniors

  2013cites this paper
• "Trabecular Bone Score" (TBS): an indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism.

  2013cites this paper
• Bariatric surgery, bone loss, obesity and possible mechanisms

  2013cites this paper
• The Effect of Endogenous Parathyroid Hormone in Iliac Bone Structure and Turnover in Healthy Postmenopausal Women

  2013influential citation
• Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism.

  2013cites this paper
• Parathyroid Hormone: Anabolic Treatment of Osteoporosis

  2013cites this paper
• Neuromuscular system findings in thyroid and parathyroid disease

  2013cites this paper
• The Skeletal Actions of Parathyroid Hormone in Primary Hyperparathyroidism and in Osteoporosis

  2013cites this paper
• Skeletal effects of primary hyperparathyroidism: bone mineral density and fracture risk.

  2013cites this paper
• New insights into the effects of primary hyperparathyroidism on the cortical and trabecular compartments of bone.

  2013cites this paper
• Teriparatide in the treatment of non-unions: scientific and clinical evidences.

  2013cites this paper
• Bone marrow ablation demonstrates that excess endogenous parathyroid hormone plays distinct roles in trabecular and cortical bone.

  2012cites this paper
• Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: A one‐year prospective controlled study using high‐resolution peripheral quantitative computed tomography

  2012cites this paper
• Primary hyperparathyroidism.

  2012cites this paper
• Ronacaleret, a calcium‐sensing receptor antagonist, increases trabecular but not cortical bone in postmenopausal women

  2012cites this paper
• Effect of renal function on skeletal health in primary hyperparathyroidism.

  2012cites this paper
• Bone disease in primary hyperparathyrodism

  2012cites this paper
• PTH 1-84: bone rebuilding as a target for the therapy of severe osteoporosis.

  2012cites this paper
• Prevalence of primary hyperparathyroidism among patients with low bone mass.

  2012cites this paper
• Circulating osteogenic precursor cells in type 2 diabetes mellitus.

  2012cites this paper
• Parathyroid Hormone as an Anabolic Skeletal Therapy

  2012cites this paper
• Bone Density and Fracture Risk in Primary Hyperparathyroidism

  2012cites this paper
• "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density"

  2011cites this paper
• Parathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism.

  2011cites this paper
• PTH(1–84) administration reverses abnormal bone‐remodeling dynamics and structure in hypoparathyroidism

  2011cites this paper
• Forearm Bone Mineral Density in Familial Hypocalciuric Hypercalcemia and Primary Hyperparathyroidism: A Comparative Study

  2011cites this paper
• Effect of cinacalcet on bone mineral density of the radius in hemodialysis patients with secondary hyperparathyroidism.

  2011cites this paper
• Regulation of bone quality and calcium absorption in obesity and during caloric restriction in women

  2011cites this paper
• Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism.

  2011cites this paper
• A 7‐day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover

  2011influential citation
• Parathyroid hormone for osteoporosis treatment

  2011cites this paper
• Inhibition of antigen presentation and T cell costimulation blocks PTH‐induced bone loss

  2010cites this paper
• Skeletal microstructural abnormalities in postmenopausal women with chronic obstructive pulmonary disease

  2010cites this paper
• PTH 184 in the treatment of osteoporosis

  2010cites this paper
• Bone histomorphometry: a concise review for endocrinologists and clinicians.

  2010cites this paper
• Are Osteoclasts Needed for the Bone Anabolic Response to Parathyroid Hormone?

  2010cites this paper
• Clinical Use of Parathyroid Hormone in Osteoporosis

  2010cites this paper
• Disruption of PTH Receptor 1 in T Cells Protects against PTH-Induced Bone Loss

  2010cites this paper
• Osteoporosis y Metabolismo Mineral

  2010cites this paper
• Treatment of Male Osteoporosis with Parathyroid Hormone

  2010cites this paper
• Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study.

  2010cites this paper
• Management of skeletal health in patients with asymptomatic primary hyperparathyroidism.

  2010cites this paper
• PTH 1-84 in the treatment of osteoporosis

  2010cites this paper
• Changes in Bone Mineral Density, Body Composition and Adiponectin Levels in Morbidly Obese Patients after Bariatric Surgery

  2009cites this paper
• Coupling PTH and arrestins to uncouple bone formation from resorption: A new road to osteoporosis anabolic therapy?

  2009influential citation
• Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism.

  2009cites this paper
• ß-arrestin2 regulates age-related and parathyroid hormone-induced changes in the expression of genes involved in bone remodeling/turnover

  2009cites this paper
• Clinical Vignette: PTH(1–34) Replacement Therapy in a Child With Hypoparathyroidism Caused by a Sporadic Calcium Receptor Mutation

  2009influential citation
• Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy

  2009cites this paper